Identification of mild cognitive impairment subtypes predicting conversion to Alzheimer’s disease using multimodal data-Reference-Cited by-同舟云学术

Identification of mild cognitive impairment subtypes predicting conversion to Alzheimer’s disease using multimodal data

Published:2022 Issue: Volume:20 Page:5296-5308
ISSN:2001-0370
Container-title:Computational and Structural Biotechnology Journal
language:en
Short-container-title:Computational and Structural Biotechnology Journal

Author:

Kikuchi Masataka,Kobayashi Kaori,Itoh Sakiko,Kasuga Kensaku,Miyashita Akinori,Ikeuchi Takeshi,Yumoto Eiji,Kosaka Yuki,Fushimi Yasuto,Takeda Toshihiro,Manabe Shirou,Hattori Satoshi,Nakaya Akihiro,Kamijo Kenichi,Matsumura Yasushi

Funder

Alzheimer's Disease Neuroimaging Initiative

Japan Agency for Medical Research and Development

Japan Science and Technology Corporation

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Elsevier BV

Subject

Computer Science Applications,Genetics,Biochemistry,Structural Biology,Biophysics,Biotechnology

Reference40 articles.

1. World Alzheimer Report 2021: Journey through the diagnosis of dementia. [Available from: https://www.alzint.org/resource/world-alzheimer-report-2021/.

2. Alzheimer's disease drug development pipeline: 2019;Cummings;Alzheimers Dement (N Y),2019

3. Mild cognitive impairment as a clinical entity and treatment target;Petersen;Arch Neurol,2005

4. Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts;Farias;Arch Neurol,2009

5. Distilling heterogeneity of mild cognitive impairment in the national alzheimer coordinating center database using latent profile analysis;Blanken;JAMA Netw Open,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-view imputation and cross-attention network based on incomplete longitudinal and multimodal data for conversion prediction of mild cognitive impairment;Expert Systems with Applications;2023-11

2. Knowledge-guided Deep Temporal Clustering for Alzheimer’s Disease Subtypes in Completed Clinical Trials;2023-10-13

3. Polygenic effects on the risk of Alzheimer’s disease in the Japanese population;2023-10-06